BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32095117)

  • 1. Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death.
    Baumert HM; Metzger E; Fahrner M; George J; Thomas RK; Schilling O; Schüle R
    Cancer Cell Int; 2020; 20():52. PubMed ID: 32095117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.
    Totonji S; Ramos-Triguero A; Willmann D; Sum M; Urban S; Bauer H; Rieder A; Wang S; Greschik H; Metzger E; Schüle R
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KMT9 Controls Stemness and Growth of Colorectal Cancer.
    Berlin C; Cottard F; Willmann D; Urban S; Tirier SM; Marx L; Rippe K; Schmitt M; Petrocelli V; Greten FR; Fichtner-Feigl S; Kesselring R; Metzger E; Schüle R
    Cancer Res; 2022 Jan; 82(2):210-220. PubMed ID: 34737213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer.
    Koll FJ; Metzger E; Hamann J; Ramos-Triguero A; Bankov K; Köllermann J; Döring C; Chun FKH; Schüle R; Wild PJ; Reis H
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity.
    Wang S; Klein SO; Urban S; Staudt M; Barthes NPF; Willmann D; Bacher J; Sum M; Bauer H; Peng L; Rennar GA; Gratzke C; Schüle KM; Zhang L; Einsle O; Greschik H; MacLeod C; Thomson CG; Jung M; Metzger E; Schüle R
    Nat Commun; 2024 Jan; 15(1):43. PubMed ID: 38167811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.
    Metzger E; Wang S; Urban S; Willmann D; Schmidt A; Offermann A; Allen A; Sum M; Obier N; Cottard F; Ulferts S; Preca BT; Hermann B; Maurer J; Greschik H; Hornung V; Einsle O; Perner S; Imhof A; Jung M; Schüle R
    Nat Struct Mol Biol; 2019 May; 26(5):361-371. PubMed ID: 31061526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITRAQ-Based Proteomics Analysis of Triptolide On Human A549 Lung Adenocarcinoma Cells.
    Li F; Zhao D; Yang S; Wang J; Liu Q; Jin X; Wang W
    Cell Physiol Biochem; 2018; 45(3):917-934. PubMed ID: 29428961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of G9a attenuates cell proliferation via the mitochondrial apoptosis pathway in lung adenocarcinoma].
    Wan HJ; Lyu W; Yu L; Zhou ZY; Hu YJ; Hu J
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):13-17. PubMed ID: 28104027
    [No Abstract]   [Full Text] [Related]  

  • 9. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
    Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
    J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis.
    Shao C; Zhao L; Wang K; Xu W; Zhang J; Yang B
    World J Surg Oncol; 2012 Aug; 10():160. PubMed ID: 22866867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Elemonic acid inhibits the cell proliferation of human lung adenocarcinoma A549 cells: The role of MAPK, ROS activation and glutathione depletion.
    Wu TT; Lu CL; Lin HI; Chen BF; Jow GM
    Oncol Rep; 2016 Jan; 35(1):227-34. PubMed ID: 26530631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of thymosin beta 10 inhibiting the apoptosis 
and prompting proliferation in A549 cells].
    Li Z; Qu L; Zhong H; Xu K; Qiu X
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):783-8. PubMed ID: 25404268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen gas inhibits lung cancer progression through targeting SMC3.
    Wang D; Wang L; Zhang Y; Zhao Y; Chen G
    Biomed Pharmacother; 2018 Aug; 104():788-797. PubMed ID: 29852353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
    Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
    Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone methyltransferase SETD1A participates in lung cancer progression.
    Du M; Gong P; Zhang Y; Liu Y; Liu X; Zhang F; Wang X
    Thorac Cancer; 2021 Aug; 12(16):2247-2257. PubMed ID: 34219384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective and new potent drug combination: Histone deacetylase and Wnt/β-catenin pathway inhibitors in lung carcinoma cells.
    Akgun O; Erkisa M; Ari F
    J Cell Biochem; 2019 Sep; 120(9):15467-15482. PubMed ID: 31037769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.